Femi Ogunleye/LinkedIn
May 17, 2026, 17:35
Femi Ogunleye: New PhD Publication on Targeted Thrombolysis
Femi Ogunleye, Doctoral Researcher at Shenzen Institute of Advanced Technology University of Chinese academy of science, shared a post on LinkedIn:
“I am thrilled to announce our latest publication, as a part of my PhD work, titled Platelet-membrane-coated nanoparticles enable safe and targeted thrombolysis with preserved neurovascular integrity.”
Title: Platelet-membrane-coated nanoparticles enable safe and targeted thrombolysis with preserved neurovascular integrity
Authors: Ziying Feng, Ogunleye Femi Abiola, Guojun Huang, Tianfang Kang, Fan Xu, Ping Gong, Junlei Chang, Hong Pan, Yinzhong Ma
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?
-
Aug 31, 2026, 14:24Akl Fahed: Do Lifelong Differences in LDL Cholesterol Influence the Risk of Venous Thromboembolism?
-
Aug 31, 2026, 14:23Accelerating CAR-T Access Through Policy and System Reform – American Society of Hematology
-
Aug 31, 2026, 14:21Shirya Rashid: Does Bempedoic Acid Influence Venous Thromboembolism Risk?
-
Aug 31, 2026, 14:14Jason Andrade: SINGLE-AF Trial Validates Early Anticoagulation in AF
-
Aug 31, 2026, 14:12Leonardo Roever: Diagnosis and Management of Natural Anticoagulant Deficiencies
-
Aug 31, 2026, 14:07Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery